# NDR Medical Technology

> NDR Medical Technology is a Singapore-based deep-tech company building AI-empowered interventional robotics for minimally invasive, image-guided surgery. Its Automated Needle Targeting (ANT) platform combines hardware and software to plan and align percutaneous needle placement with roughly ±1mm accuracy using a hospital's existing imaging equipment. Its flagship ANT-X robot received U.S. FDA 510(k) clearance in 2023 as the first automated device to aid kidney access for percutaneous nephrolithotomy, while ANT-C brings AI CT-based lesion targeting to procedures across the lung, liver, kidney and spine.

- **Founded:** 2014
- **Headquarters:** Singapore
- **Founders:** Alan Goh (Co-Founder & CEO), Jason Ng (Co-Founder)
- **Team size:** ~14 employees
- **Products:** ANT-X, ANT-C, Automated Needle Targeting (ANT) platform
- **Notable:** FDA 510(k) clearance for ANT-X (2023) - first automated robotic device to aid kidney access for PCNL, CE approval for kidney stone procedures in Europe, Forbes Asia 100 To Watch (2021)

## Products & services

- **ANT-X** — An interventional robot integrating C-arm fluoroscopy and AI software to achieve safe, accurate percutaneous needle placement. FDA 510(k) cleared as the first automated device to aid kidney access for Percutaneous Nephrolithotomy (PCNL).
- **ANT-C** — A smart lesion targeting system that uses AI with CT-scan imaging to automate lesion detection, needle path planning and needle targeting for procedures across the lung, liver, kidney and spine.
- **Automated Needle Targeting (ANT) platform** — The underlying hardware-plus-software system for automated needle positioning and alignment, achieving accuracy of up to about ±1mm using a hospital's existing imaging equipment.

## Achievements

- FDA 510(k) clearance for ANT-X (2023) - first automated robotic device to aid kidney access for PCNL
- CE approval for kidney stone procedures in Europe
- Forbes Asia 100 To Watch (2021)
- iF Design Award (2021)
- 2022 JVIR Editor's Award for Outstanding Laboratory Investigation for the ANT-C research paper
- First Neurospine (discoplasty) procedure conducted in Singapore (June 2023)

## Latest updates

- **2023-06** — ANT-X granted U.S. FDA 510(k) clearance, paving the way for image-guided surgeries in the US.
- **2023-06** — First Neurospine discoplasty procedure successfully conducted in Singapore, extending the platform beyond urology.
- **2023-01** — ANT-X system entered clinical use at Wakayama Medical University Hospital in Japan.
- **2022-01** — ANT-C research paper received the JVIR Editor's Award for Outstanding Laboratory Investigation.

## Links

- Website: https://ndrmedical.com
- LinkedIn: https://www.linkedin.com/company/ndr-medical
- YouTube: https://www.youtube.com/channel/UC2a_2iUR6-iNCigW1ZrHDZw

---

Profile page: https://yespress.io/ndr-medical-technology-pte-ltd
Published by YesPress — https://yespress.io
Last updated: 2026-07-25